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In the diagnosis of infectious disease precipitin and agglutinin reac- 
tions have assisted in the identification of the invading organism, when 
the patient's serum has been tested with suspected organisms or when 
antigenic material from the patient (1) has been tested against antisera. 
Agglutination has been used also in the quantitative determination 
of the antibody in antityphoid and antimeningococcus sera.  For the 
standardization of diphtheria antitoxin Ramon (2; see also reference 3) 
suggested a test-tube method based on the formation of a  floceulent 
precipitate  when  toxin  and  antitoxin  were  combined  in  definite 
proportions. 
The present paper records investigations concerning the parallelism 
of the precipitin with the protective antibody in antipneumococcus 
sera.  The quantitative determination of antibody in antipneumococ- 
cus sera is based on the relative reactivity of the precipitin and the 
protective antibody; the question of their identity is not raised. 
Agglutination tests in pneumonia require the use of uniform cul- 
tures; they thus share with the animal protection test the disadvantage 
of  possible  biological irregularities.  Precipitin  tests,  however,  are 
carried out with a reproducible  non-cellular antigen of a definite chemi- 
cal composition. 
* This investigation was  carried out by means of the Lucius N. Littauer Fund 
for Pneumonia Research. 
t This  communication  is part  of  a  thesis  to  be  submitted  by  Mac  Fried- 
lander in partial fulfilment of the requirements for the degree of Doctor of  Phi- 
losophy in Bacteriology at New York University. 
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Method. 
The precipitin indices for a  number  of antipneumococcus sera and  antibody 
preparations were determined by the precipitin tests  described in  the preceding 
paper.  The study of the zonal phenomena permits the elimination of  these irregu- 
larities. 
Only the higher values furnished by  multiplication of serum and precipitinogen 
dilution were used in calculating the precipitin inctices, all individual values smaller 
than one-half of the maximal value were d'sregarded in estimating the average of 
each test.  Precipitin index is a  millionth part of the product obtained by mul- 
TABLE  I. 
Comparison of Precipitin and Protective Antibodies  in Monovalent Type I  Sera and 
Antibody Preparations. 
No. of serum 
155 
47 
169 
90 
32 
32 
94 
Preparation 
102 
916 
Precipitin  Protective 
index  units 
4O0  100 
560  200 
1250  200-400 
700  200 
1720  400 
2550  800 
2880t 
3840  800 
234O  8OO 
7170t  800 
1920  200 
Average ratio for the first nine 
values. 
Ratio 
4.0 
2.8 
4.1 
3.5 
4.3 
3.2 
3.6 
4.8 
2.9 
9.0 
9.6 
3.8 
Reference 
Table IX (d) 
Table IX (d) 
Table IV 
Table VII preceding paper 
Tables I and VI preceding paper 
Tables HI and XI preceding paper 
Table IV 
Table IV 
Table X preceding paper 
See page 88 
t With addition of 10 per cent normal horse serum. 
tiplying the  dilution of  the antiserum by the dilution of the  antigen.  For de- 
tails ~ee the preceding paper. 
The  proportions  of the corrected precipitin index to the protective 
units of the same antibody  solution were compared  and  an  unantici- 
pated  constant  relation was revealed. 
The  quotient  precipitin  index/protective  units  for  a  number 
of monovalent  Type  I  horses  ranged  between  2.8  and  4.8 with  an 
average  of  3.7.  For  some  monovalent  Type  III  horses  the FRIEDLANDERj  SOBOTKA~  AND  BANZHAF 
TABLE  II. 
Precipitin and Protective Antibodies in Monovalent Type 111 Sera. 
81 
No. of serum 
125 
126 
127 
128 
302 
Precipitin  Protective 
index  units 
160  4, 8, 10 
192 
220  4 
135 
128  4 
85  4-10 
575  10 
770  10 
6150  80 
Average ratio of all, values except the 
two last.. 
Ratio 
16-48 
34-55 
32 
8-21 
58 
77 
77 
Reference 
Table V preceding paper 
Table V 
Table V preceding paper 
Table V 
Table V 
Table V 
Table X 
Table X 
Table X 
34 
TABLE  III. 
Rdatien between Preci Oitin Index and Protective Potency for Pdyvalent A ntisera. 
Type I  Type III 
Horse No.  Duration of 
~eatment 
mo$. 
3079  28 
3180  28 
3332  22 
3335  22 
3514  II 
3530  10 
3531  I0 
3635  6 
364O  6 
3639  6 
P.  I. 
720 
530 
530 
350 
400 
480 
60 
240 
60 
<40 
P.U. 
1000  >340 
500  320 
1000 
400  >340 
500 
< 500  > 190 
100  72 
200 
200  256 
50 
50 
100 
50 
50 
A 
.  (upper 4 horses .......... 
verage mtio  ~lower 6 horses ........... 
Ratio 
0.72 
1.0~ 
0.52 
1.35 
1.0C 
>0.7( 
2.0 
4.0 
2.4 
1.2 
2.4 
4.8 
1.2 
<0.8 
0.9 
2.3 
P.u.  P.  i° 
>3 
3  10 
(20 
>3  10' 
(201 
>1  (8 
2 
(4 
2  10 
(20 
> 192 
45 
30 
5O 
Ratio 
32 
(16) 
34 
(17) 
(24) 
36 
(18) 
26 
(13) 
23 
25 
24 
The parenthesized figures for protective units in Type HI are based on 72 hours 
delay of death rather than on survival over 96 hours; on account of  the pro-zone 
familiar  in  Type  III  pneumococcus  mouse  tests  no  survivals  occurred. 82  ANTIPNEUMOCOCCUS  SERA.  II 
quotient  ranged  between  the  extremes  of 8 and 58 with an  average 
of  34  (Tables  I  and  II).  When  comparing  these  figures  with 
those  of  Type  I  the  almost  ten  times  greater  precipitin  power 
associated  with  the  protective  potency  in  Type  III  is  striking. 
If  we  discount  this  difference  by  referring  the  higher  precipitin 
index per protective unit in Type III to the higher  specific activity 
of equal  weights  of  the precipitinogen  rather  than  of the antibody, 
there is seen to be a similar ratio between precipitin and protective ac- 
tivity of the antisera for  the  two types investigated. 
For a number of polyvalent horses  1 decidedly lower values for the 
quotient precipitin index/protective units were observed.  In Type I 
they ranged between 0.7 and 2.4 with  an  average  of  1.75  and  with 
extreme values of 0.53 and 4.8.  For Type III in polyvalent horses 
the quotient ranged among the lower values of those given above for 
monovalent sera of  this type, the average being 24 (Table III). 
A decrease in precipitin activity was also observed when adding one 
heterologous monovalent serum to an equal amount of another. 
Serum 90, Type I  shows a precipitin index of 700 and upon the addition  of 
Serum 129, Type II, the precipitin index was only 60.  Serum 126, Type  IIL 
decreased upon addition of No. 129 from 135 to 32. 
If the Type I values of the polyvalent horses were arranged accord- 
ing to the duration of the treatment  they could be divided into two 
groups; one comprising four horses under pneumococcus treatment for 
2 years had quotients ranging below 1.35 with an average of 0.9, while 
another group of horses under treatment for no longer than 1 year had 
values above 1.2  with an average of 2.3. 
This observation indicates that  the duration  of the treatment  in- 
fluences the proportion of the two antibody activities.  This became 
evident from an experiment on two Type I horses whose immunization 
we observed from the onset.  It was found that the quotients for bleed- 
ings after 37 days were about twice as  high as those after 114 days; 
the protective potencyreached greater values at a slower rate than the 
precipitin. 
When the precipitin test was applied to refined antibody prepara- 
1  Samples of these were supplied through the kindness of Dr.  Stanley Beard 
of the Lederle Antitoxin Laboratories, Pearl River, New York. FRIEDLANDER~  SOBOTKA~  AND  BANZHAF  83 
tions the quotients obtained  were higher than from the crude sera in 
our experiments.  We  observed  values as high  as  9  in  Type I  and 
above 70 in Type III.  There is some doubt whether this difference 
arises  during  the  refining  process by a  selective fractionation  or is 
simply due to a  lesser proportionalism between  potency and concen- 
tration  in  concentrated  solutions. 
When making due  allowance for the  various influences noted and 
TABLE  IV. 
Precipitin  Test of Antipneumococcus Sera,  Type 1, No. 94 and No.  169  and  of 
Antibody Preparation "f" Prepared by L. D. Felton's Procedure (4). 
Serum No. 
94 
169 
,,f,, 
Dilution of 
serum 
20 
40 
8O 
120 
20 
40 
80 
120 
160 
240 
20 
40 
60 
120 
Dilution of soluble specific substance in millions 
4 
Preeipitin index 
(pro-zone) 
(post-zone) 
++++ 
+  4- 
96  128  "P. x." 
(<320) 
(<640) 
384O 
3840 
3840 
1280 
64O 
< 1280  1250 
1440 
1920 
(<  960) 
-4-  +  2560 
2560  2340 
1920 
( < 1920) 
discussed in the present  and in the preceding paper a  fairly accurate 
idea  of the  amount of antibody  contained in  an  antipneumococcus 
serum  can be obtained.  The  determination of the precipitin index 
may replace the  slow mouse test in the course of immunizing horses 
as well as during refining processes; for final controls animal tests will 
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EXPERIMENTAL  PART. 
In  the  following  tables data  are  collected for  several monovalent 
Type  I  and Type  III  sera.  Some of them like No. 94, Type  I, Table 
IV, and No.  125 and No.  127, Type  III, Table V, show a pro-zone and 
TABLE  V. 
Preclpitin Test of Antisera 125 to 128, Type IIL 
Dilution I  Dilution of soluble specific substance III in millions 
of serum  0.05  0.1  0.2  0.3  0.4  0.6  0.8  1.2  1.6  2.4  3.2  4.8  6.4  9.6  12.8 
P.I. 
No. 125 
10  +  +  +  +  +  +  -F  +  + 
20  +  +  +  +  +  +  +  +  +  ± 
40  -  +  +  +  +  +  +  +  +  +  +  + 
80  -)-  -  + 
120  .... 
(16) 
(4O 
192 
(24) 
No.  126 
I0  +  +  +  +  +  +  +  +  +  +  +  +  +  +  ±112 
20  +  +  +  +  +  +  +  +  +  +  +  +  +  ±  -- 160 
4o  ±  +  +  +  +  +  +  +  ±  ±  (64 
8o  +  ±  -  (40) 
120  +  ±  (42 
No. 127 
10  +  +  +  +  +  +  +  +  +  -  -  - 
20  +  +  +  +  +  +  +  +  + 
40  +  +  +  +  +  +  +  +  +  +  +  - 
8O  +  +  +  -  +  - 
120  --  --  -- 
(16 
(32) 
128 
] (48) 
No. 128 
10  +  +  +  +  +  +  +  +  +  +  +  +  +  64 
20  +  +  +  +  +  +  +  +  +  +  +  +  --~  96 
4O  ±  -  +  +  +  +  +  +  +  +  96 
80  +  ±  ±  -  (40 
120  ±  +  +  ±  +  --  72 
in these instances only the high values obtained from higher serum dilu- 
tions were taken into consideration.  Values lower than 50 per cent of 
the highest value in a  test are parenthesized and  were disregarded. 
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polyvalent  horses,  immunized  against  three  types,  are  given.  The 
figures are the dilution products or precipitin indices for the individual 
serum dilutions given in the first column.  Pro-zones of more or less 
extent, maybe  observed in Sera 3079, 3180, 3640 and others for both 
types, in Sera 3514 and 3530 for Type I, and almost in all sera for serum 
dilution  1:5  for  Type  III. 
TABLE  VI. 
Synopsis  of Precipitin Tests of Sera Obtained  frown Ten Polyvalent Horses (Types I, 
II, III). 
Precipitin indices for single serum dilutions given.  Figures in parenthesis 
disregarded in computation of average P.I. 
Dilution of  Horse No. 
Type I 
5 
10 
20 
40 
80 
160 
(80)  (40)  [  -  320 
(80)  (80)  ][ ~  320 
(80) 1/160)  (240) 320 
(30)  120) I  40 [(12o)i(<2o)[  (120)  [ (60)  60 I  (80) 1(<20) 
(160) 1(160)  4o [  (40)  60 
(160) [(160)  80 I  (80)  60 
320  I 320  (<40)[  240  (<40) 
480  I 640  (<80) I 240  1(<80) 
Less 
than 
40 
Type III  ~  ~ " 
5 
10 
20 
40 
gO 
160 
(64)](>128)]  - >128 
(64)  (96)[  --  192[ 
I  (48)1  (128)[  -l>286  I 
I  2561  2561  2561 2561 
I >256 /  192[  >256[  128 I 
[>512 t  >512[  >512[  (96)] 
>128 >128  32  (8)  32 
>256  >256  32  I  32 I  48 
64  I  2561  192 [  641  321  64 
64  [  384 [  (64)/(<24) l  28 [  28 
I  256 [  (128)[(<(16)l(<i6) /  16  64 
96  [  (96)[(<32)]  --  [  --  [(<32) 
t see Table VII.  ~ see Table VIII. 
Examples for both regular and pro-zone sera of each type are given 
in  Tables  VII  and  VIII. 
A synopsis of these values is given in Table  III, page  81, where  the 
precipitin indices as calculated from Table VI are listed in the third and 
sixth columns.  The protective units in the fourth and seventh columns 
of Table III, and in the third columns of Tables I and II were obtained 
from mouse tests, carried out according to the government  standards 
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TABLE  VII. 
Reaction of Soluble Specific Substance Type f  with Polyvalent Antipneumococcus 
Sera. 
Serum 3335 (Very Regular Test). 
Dilution of 
serum 
5 
10 
20 
40 
80 
120 
0.5 
++ 
Dilution of soluble specific substance in millions 
T 
++ 
2 
++ 
4  V-- 
+ 
-4- 
8 
+V 
16 
+ 
32 
5 
64  --7-~ 
128 
Serum 3180 (Pro-Zone Type). 
5 
10 
20 
40 
80 
120 
•  +  ++  -  _  _ 
m 
TABLE  VIII. 
Reaction of Soluble Specific Substance Type III with Polyvalent A ntipneumococcus 
Sera. 
Serum 3639 (Regular). 
Dilution of soluble specific substance in millions 
Dilution of 
serum 
5 
10 
20 
40 
80 
120 
0.2 
+ 
0.4 
m 
m 
0.6 
+ 
+ 
0.8 
+ 
+ 
+ 
-4- 
1.6 
+ 
+ 
+ 
3.2 
+_ 
6.4 
+ 
-4- 
12.8 
m 
Serum 3640 (Pro-Zone). 
5 
10 
20 
40 
80 
120 
m  M  ++  + 
-4- 
++ 
+_ 
m 
+ 
m  B ~FRIEDLANDER~  SOBOTKA~  AND  BANZHAF  87 
TABLE  IX. 
Development of Precipitin and Protective Antibodies  against  Type I  Diplococcus 
Pneumonio~ in Two Horses. 
Dilution of serum 
10 
20 
40 
80 
160 
Average P.I. 
Protective units 
Ratio 
Precipitin indices for individual serum dilutions.  Duration of 
immunizing treatment. 
(a)  (b)  (c)  (d) 
0  37  72  114 days 
47  155  47  155  47  155  47  155 
Nil Nil 
Nil Nil 
(60)  (120) 
(80)  160 
(120)  240 
640  320 
640  (<160) 
640  240 
80-100  40 
6.4--8.0  6.0 
(<40)  (<40) 
(80)  (40) 
(160)  (80) 
480  320 
480  640 
480  480 
80  100 
6.0  4.8 
(30)  (160) 
(40)  (60) 
(240)  (80) 
640  320 
480  480 
560  400 
200  100 
2.8  4.0 
TABLE X. 
Precipitin Test of Serum 302, Type 111, and of Two Globulin Fractions A  and B, 
Concentrated 16 Times and 14 Times Compared with the Original Serum 302. 
Dilution  Dilution of precipitinogen in million~ 
of anti-  P,I.  body solu- 
tion  0.2  0.4  0.8  1.2  1.6  3.2  4.8  6.4  9.6  12.8  25.6  51.2 
No. 302 
20  +  +  +  +  +  (32) 
40  +  +  +  +  +  +  (128) 
80  +  +  +  +  +  +  +  +  512 
16o  +  +  +  +  ÷  +i  ~:  640 
320  ......  i  l 
A  i 
80  +  +  +  +  +  +  +  -  -  (384) 
160  +  +  +  +  +  +  (512) 
320  +  +  +  +  +  +  1624 
480  +  768 
B 
160 
320 
480 
A+B 
160 
+  +  +  +  +  +  +  +  +  +  +  4-  6144 
+  +  +  +  (1536) 
+  +  +  +  ....  (1536) 
+  +  +  +  +  +  +  +  +  +  +  -4-  Stronger reac- 
tions  than  E 
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York, by Miss G. M. Cooper under the direction of Dr. W. H. Park, 
and in the Testing Department of the Lederle Antitoxin Laboratories, 
Pearl River, New York, by Miss F. L. Clapp, to whom we have to ex- 
press our thanks for their kind cooperation. 
The influence of the duration of the.treatment on the quotient pre- 
eipitin index/protective power was studied in two monovalent horses, 
No. 47 and No.155,  for which the experimental data are to be found 
in Table IX.  The quotients were 6 to 8 after 5 weeks, 4.8 to 6.0 after 
10 weeks and 2.8 to 4.0 after 16 weeks3 
Two globulin  fractions  were  obtained by the  ammonium  sulfate 
method (6) from Serum 302  (Table X).  The first was concentrated 
to one-sixteenth, the second to one-fourteenth of the original volume. 
The first fraction contained only ten mouse units per cc. like the start- 
ing material,  in the second a  concentration of 80 units was attained. 
The ratio precipitin/protection,  already as high  as 58 in  the  original 
serum, rose to 77 for the globulins.  By mixing the two globulin frac- 
tions  in equal amounts  an effect was observed similar  to those dis- 
Cussed on page 65 of the preceding paper. 
The precipitin  values for Preparation  916, Type I,  200 protective 
units  (Table I),  were 
for a serum dilution of 10  1280 
20  2560 
40  160 
80  8O 
160  160; 
in this preparation,  as in No. 102 of Table VI in  the preceding paper, 
the precipitin activity was very high as compared with the protective 
potency. 
SUM'MARY. 
The precipitin indices for a number of monovalent and polyvalent 
antipneumococcus sera were determined under known conditions, and 
found to vary as did the number of protective units. 
The ratio precipitin index/protective units in monovalent sera was 
2 Forster (5), investigating the relation between the time elapsed since immun- 
ization and the precipitin titer,  observed the development of a post-zone during 
the "secondary stage." FRIEDLANDER~ SOBOTKA~ AND  BANZHAF  89 
found to lie between 2.8 and 4.8 for Type I and to be about ten times 
greater for Type III. 
Lower values were found in  polyvalent horses and when mixing 
heterologous monovalent sera with  each other. 
The influence of the duration of treatment upon the quotient was 
studied. 
Several  refined and concentrated preparations showed a  relative 
increase in precipitin activity. 
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